A. Marc Gillinov, MD

216.445.8841

A. Marc Gillinov, MD

Appointed: 1997

A. Marc Gillinov, MD
Department: Thoracic and Cardiovascular Surgery
Institute Experience Officer, Heart & Vascular Institute
Location: Cleveland Clinic Main Campus
Mail Code J4-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.8841
DeskDesk:216.444.2480
WorkFax:216.636.6988
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Marc Gillinov, MD, is a staff cardiac surgeon in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is board-certified by the American Board of Surgery and the American Board of Thoracic Surgery. He holds the Judith Dion Pyle Chair in Heart Valve Research at Cleveland Clinic. In addition, he is Surgical Director of the Center for Atrial Fibrillation at Cleveland Clinic.

In response to patients’ questions, Dr. Gillinov recently worked with Cleveland Clinic cardiologist Dr. Steven Nissen to write Heart 411: The Only Heart Guide You Will Ever Need. The goal of the book is to help people learn about heart health and live a heart-healthy lifestyle.

Specialty interests: Mitral valve repair, robotic mitral valve surgery, robotic heart surgery, aortic valve replacement, minimally invasive heart surgery, heart valve surgery, heart valve repair, atrial fibrillation.

Number of Procedures Performed: Cleveland Clinic surgeons perform more than 4,000 heart surgeries each year. Of these, Dr. Gillinov performs approximately 400 surgeries per year. The majority of Dr. Gillinov’s procedures are heart valve procedures, especially mitral valve surgery. Dr. Gillinov performs more mitral valve surgeries each year than any other surgeon in the world.

Success Rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx

Education and Training:  A Cleveland native and graduate of Hawken School, Dr. Gillinov first worked at Cleveland Clinic in 1978. After a close family member’s successful heart surgery at Cleveland Clinic, Dr. Gillinov became interested in learning more. He spent his summers during high school at Cleveland Clinic, working as a researcher and assistant in the cardiac surgery operating suite.

After graduating summa cum laude from Yale University, Dr. Gillinov entered Johns Hopkins University School of Medicine, where he ranked first in his class. Dr. Gillinov received his clinical and advanced training in general surgery and cardiac and thoracic surgery at The Johns Hopkins Hospital. After completing his education and training, he returned to Cleveland Clinic and joined the cardiac surgery staff in 1997.

Publications and Speaking: Dr. Gillinov is a recognized expert in mitral valve repair surgery, robotic heart surgery and in the study and treatment of patients with atrial fibrillation. He has been instrumental in the development of new, less invasive treatment approaches for patients with mitral valve disease and atrial fibrillation. He has been invited to give hundreds of lectures at hospitals, academic meetings and seminars in the United States and abroad.

Dr. Gillinov has written more than 250 publications, eight continuing medical educational films and contributed 19 chapters to medical/surgical textbooks. He has submitted patent applications for several innovations, including a patent disclosing new techniques for valve repair for which he received a Cleveland Clinic Award for Innovation. Dr. Gillinov has been instrumental in ushering in a new era in medicine with his contributions to the scientific development of percutaneous approaches to treating patients with heart valve disease.

Dr. Gillinov is a current or past member of 10 scientific societies, and he has been invited to join the editorial review board or act as an editorial reviewer for 15 scientific periodicals. He is the medical editor of Cleveland Clinic’s Cardiac Consult, and has served on the editorial boards of e-Cleveland Clinic, The Heart Surgery Forum, Innovations, the Journal of Thoracic and Cardiovascular Surgery, and the Journal of Cardiac Surgery.

About Dr. Gillinov: “My greatest strength as a heart surgeon has two components. First, I can tailor the surgical approach to the patient, ranging from robotic and minimally invasive surgery to standard surgery, using the method that is best and safest. Second, I do this with compassion. In every instance and at every decision, I consider what I would want if I were the patient.”

Leisure time activities: In his free time, Dr. Gillinov enjoys playing tennis, running, and taking his children to tennis tournaments around the country.

Professional Highlights

  • Co-author of "Heart 411: The Only Heart Guide You Will Every Need."
  • Judith Dion Pyle Chair in Heart Valve Research
  • Cleveland Clinic Innovator Award for New Techniques in Mitral Valve Repair
  • Dr. Gillinov has one of the world's largest practices in robotic and minimally invasive mitral valve repair surgery

Education & Fellowships

Fellowship - Johns Hopkins Hospital
Cardiac Surgery
Baltimore, MD USA
1997
Residency - Johns Hopkins Hospital
Cardiac Surgery
Baltimore, MD USA
1996
Residency - Johns Hopkins Hospital
General Surgery
Baltimore, MD USA
1994
Internship - Johns Hopkins Hospital
General Surgery
Baltimore, MD USA
1989
Medical School - Johns Hopkins University School of Medicine
Baltimore, MD USA
1988
Undergraduate - Yale University
New Haven, CT USA
1984

Certifications

  • Thoracic & Cardiac Surgery

Specialty Interests

Mitral valve repair, robotic mitral valve surgery, robotic heart surgery, aortic valve replacement, minimally invasive heart surgery, heart valve surgery, heart valve repair, atrial fibrillation. Mitral valve repair, robotic mitral valve surgery, robotic heart surgery, aortic valve replacement, minimally invasive heart surgery, heart valve surgery, heart valve repair, atrial fibrillation

Awards & Honors

  • 2014 Best Doctors, Cleveland Magazine
  • 2008 – present The Judith Dion Pyle Chair in Heart Valve Research
  • 2007 – present Co-Principal Investigator, NIH Network for Cardiothoracic Surgical Investigations
  • 2005 – present Principal Investigator, Atrial Fibrillation Innovation Center
  • 2005, 2007 Cleveland Clinic Innovator Award for New Techniques in Mitral Valve Repair

Innovations & Patents

Dr. Gillinov has been integral to the development of several new technologies in the management of heart disease. These include:

  • Percutaneous mitral valve repair
  • Automated creation of artificial chords for minimally invasive surgical mitral valve repair
  • Left atrial appendage exclusion in atrial fibrillation
  • Minimally invasive approaches to ablation of atrial fibrillation
  • Novel technologies for minimally invasive surgical drainage systems

Memberships

Key Memberships include:

  • Member, American Association for Thoracic Surgery
  • Member, Society of Thoracic Surgeons

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/19/2014, Dr. Gillinov has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Gillinov received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Abbott Laboratories
  • AtriCure, Inc.
  • Edwards Lifesciences LLC
  • Medtronic, Inc.
  • On-X Life Technologies, Inc.
  • Tendyne Medical, Inc.

Royalty Payments. Dr. Gillinov receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • Clear Catheter Systems, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Gillinov may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • Clear Catheter Systems, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site